← Back to Search

IMT for Post-CABG Recovery

N/A

Waitlist Available

Led By Cemal Ozemek, Assoc. Prof.

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Had coronary artery bypass graft (CABG) surgery

Be able to walk independently

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 weeks

Awards & highlights

Study Summary

This trial will investigate if high-intensity inspiratory muscle training after CABG surgery can improve endothelial function and reduce arterial stiffness.

Who is the study for?

This trial is for adults over 18 who can walk on their own and have had coronary artery bypass graft (CABG) surgery. They must understand English well enough to consent and follow the study's instructions. People with recent pneumonia, other cardiothoracic surgeries, current smokers, unstable angina, certain chronic diseases, cognitive impairments or those on antipsychotic meds cannot join.Check my eligibility

What is being tested?

The trial tests if high-intensity inspiratory muscle training (IMT) improves heart and artery function after CABG surgery compared to a sham-IMT. Participants are randomly assigned to either real IMT at 60% of their max breathing power or a fake version for four weeks while cardiovascular functions are monitored.See study design

What are the potential side effects?

Potential side effects may include discomfort from intense breathing exercises and possible strain on respiratory muscles due to high-intensity training. However, specific side effects will be closely monitored throughout the study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had heart bypass surgery.

Select...

I can walk on my own without help.

Select...

I am older than 18 years.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

arterial stiffness

endothelial function

inspiratory muscle function

Secondary outcome measures

dyspnea

functional exercise capacity

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Study GroupExperimental Treatment1 Intervention

Patients who will perform inspiratory muscle training (IMT) with %60 of MIP intensity

Group II: Sham GroupPlacebo Group1 Intervention

Patients who will perform Sham-IMT

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

IMT

2015

N/A

~60

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

610 Previous Clinical Trials

1,559,415 Total Patients Enrolled

TUBİTAKUNKNOWN

6 Previous Clinical Trials

615 Total Patients Enrolled

The Scientific and Technological Research Council of TurkeyOTHER

127 Previous Clinical Trials

17,556 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to partake in this clinical venture?

"Unfortunately, this clinical trial is not currently accepting participants. Despite being initially posted on November 20th of 2021 and updated in mid-November of the same year, there are no current openings for patients. However, 119 other trials actively recruiting at this time can be found online."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

High-intensity Inspiratory Muscle Training as a Pre-cardiac Rehabilitation in Heart Disease

2023. "High-intensity Inspiratory Muscle Training as a Pre-cardiac Rehabilitation in Heart Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06127147.

All > Heart Disease